Diagnostics News and Research

RSS

Specific protein imbalance revealed in blood tests can help quantify preeclampsia risk

In a study of pregnant women in the United States, Cedars-Sinai investigators found that a specific imbalance of two placental proteins could predict which women were at risk of developing a severe form of preeclampsia, a life-threatening blood pressure disorder.

9 Nov 2022

New biomarker could aid in early diagnosis of Alzheimer’s disease

A definitive diagnosis of Alzheimer's disease (AD) was once only possible after someone had died, but recent biomarker studies have led to the development of imaging and spinal fluid tests for those still living.

9 Nov 2022

MGI opens its second overseas Customer Experience Center in Europe

MGI Tech Co. Ltd. (MGI), a company committed to building core tools and technology to lead life science, today announced the opening of its second overseas Customer Experience Center (CEC) in Europe.

9 Nov 2022

Terasaki Innovation Summit to focus on improving technological, entrepreneurial translation of personalized medicines

The Terasaki Institute for Biomedical Innovation (TIBI) will be hosting the Terasaki Innovation Summit on March 8-10, 2023, at the UCLA Meyer & Renee Luskin Center in Los Angeles.

8 Nov 2022

LSU Health New Orleans to receive patent for a noninvasive test to diagnose fatal condition in preemies

US Patent 11,493,515 will be issued to LSU Health New Orleans on November 8, 2022, for a noninvasive test that more accurately diagnoses a potentially fatal condition in premature infants.

7 Nov 2022

High-intensity treatment strategy for heart failure reduces the risk of death or hospital readmission

Ramping up medication doses quickly after being hospitalized for acute heart failure resulted in a lower risk of dying or being readmitted for heart failure within the first six months after discharge, compared to usual care, according to a featured science research presentation today at the American Heart Association's Scientific Sessions 2022.

7 Nov 2022

EKF to showcase POCT connectivity solutions at MEDICA 2022

EKF Diagnostics, a global diagnostics company, will be introducing its latest product developments and offerings at MEDICA 2022, Düsseldorf, Germany, 14-17 November.

From EKF Diagnostics 7 Nov 2022

Findings from a multi-year initiative aimed at improving HIV health outcomes

The results of a multi-year initiative aimed at improving HIV health outcomes for Black men who have sex with men (MSM) are published in a new Supplement in the peer-reviewed journal AIDS Patient Care and STDs.

7 Nov 2022

MGI Partners with Imperial College London to Establish Overseas Customer Experience Center in the UK

...

From MGI 7 Nov 2022

The Native Antigen Company expands its range of Omicron antigens to include BA.5 variant

The Native Antigen Company (part of LGC Clinical Diagnostics), one of the world’s leading suppliers of reagents that enables research into vaccines and diagnostics for emerging and endemic infectious diseases, today announced the commercial launch of its latest SARS-CoV-2 antigens for the newly designated Omicron BA.5 variant.

From The Native Antigen Company 7 Nov 2022

Llusern debuts Lodestar UTI molecular diagnostic platform at Medica 2022

UK diagnostics manufacturer, Llusern Scientific, will preview its Lodestar DX molecular platform at Medica 2022 in Dusseldorf (14-17 November).

From Llusern Scientific Ltd. 7 Nov 2022

Beckman Coulter Life Sciences and Pillar Biosciences Sign Application Development Agreement for the Biomek NGeniuS System

More companies around the world continue turning to Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, for their next generation sequencing (NGS) needs with the Biomek NGeniuS System.

From Beckman Coulter Life Sciences 4 Nov 2022

The importance of accurate pipetting in biomedical laboratory work

In this interview, Stephanie Stursberg, Group Product Manager for pipetting platforms at INTEGRA Biosciences, talks to NewsMedical about the importance of accurate and efficient pipetting in biomedical laboratory work.

From INTEGRA Biosciences 2 Nov 2022

New approach increases the likelihood of detecting antiphospholipid syndrome

The Geneva University Hospitals, the University of Geneva and their spin-off Endotelix have created the best possible target molecule for the antibodies responsible for antiphospholipid syndrome.

1 Nov 2022

Novel troponin test may help improve the treatment of heart attack patients

A new test has been developed in Turku, Finland, that helps in separating heart attack patients from those whose cardiac troponin values are elevated due to renal insufficiency.

1 Nov 2022

IHV researchers receive $7.5 million to control cancer among people living with HIV in sub-Saharan Africa

Institute of Human Virology researchers at the University of Maryland School of Medicine (UMSOM) have received two five-year awards from the National Institutes of Health's National Cancer Institute (NCI) for a total of $7.5 million.

31 Oct 2022

COVID-19 pandemic increased deaths and disease caused by tuberculosis

A new report published by the World Health Organization indicated a decrease in global spending on essential TB services from US$6 billion in 2019 to US$5.4 billion in 2021.

31 Oct 2022

New probe design offers promises for many imaging applications in biological and biomedical research

Microendoscopes are the cornerstone of modern medical diagnostics - they allow us to see what we could not even describe two decades ago.

28 Oct 2022

Novel nanotechnology triggers potent therapeutic anti-tumor immune responses against multiple cancers

A Ludwig Cancer Research study has developed a novel nanotechnology that triggers potent therapeutic anti-tumor immune responses and demonstrated its efficacy in mouse models of multiple cancers.

28 Oct 2022

AI models improve the accuracy of diagnosing coronary artery disease

Several recent discoveries show that the accuracy of diagnosing coronary artery disease and predicting patient risk is improved with the help of artificial intelligence (AI) models developed by scientists in the Division of Artificial Intelligence in Medicine at Cedars-Sinai.

28 Oct 2022

Diagnostics News and Research

Specific protein imbalance revealed in blood tests can help quantify preeclampsia risk

New biomarker could aid in early diagnosis of Alzheimer’s disease

MGI opens its second overseas Customer Experience Center in Europe

Terasaki Innovation Summit to focus on improving technological, entrepreneurial translation of personalized medicines

LSU Health New Orleans to receive patent for a noninvasive test to diagnose fatal condition in preemies

High-intensity treatment strategy for heart failure reduces the risk of death or hospital readmission

EKF to showcase POCT connectivity solutions at MEDICA 2022

Findings from a multi-year initiative aimed at improving HIV health outcomes

MGI Partners with Imperial College London to Establish Overseas Customer Experience Center in the UK

The Native Antigen Company expands its range of Omicron antigens to include BA.5 variant

Llusern debuts Lodestar UTI molecular diagnostic platform at Medica 2022

Beckman Coulter Life Sciences and Pillar Biosciences Sign Application Development Agreement for the Biomek NGeniuS System

The importance of accurate pipetting in biomedical laboratory work

New approach increases the likelihood of detecting antiphospholipid syndrome

Novel troponin test may help improve the treatment of heart attack patients

IHV researchers receive $7.5 million to control cancer among people living with HIV in sub-Saharan Africa

COVID-19 pandemic increased deaths and disease caused by tuberculosis

New probe design offers promises for many imaging applications in biological and biomedical research

Novel nanotechnology triggers potent therapeutic anti-tumor immune responses against multiple cancers

AI models improve the accuracy of diagnosing coronary artery disease

Industry Focus eBook - Biotechnology (4th edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News